| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |